NKGen Biotech Presents Phase 1/2a Troculeucel Data in Alzheimer’s Disease at the 17th Annual Clinical Trials on Alzheimer’s Disease (CTAD) Conference

ws_admin

4 days ago

Wall St Business News, Latest and Up-to-date Business Stories from Newsmakers of Tomorrow